Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by carduon Nov 25, 2011 6:55pm
262 Views
Post# 19268776

RE: RE: FYI - Overpaid Investment Bank Traders

RE: RE: FYI - Overpaid Investment Bank Traders"The market price is managed by investment firms filling orders for institutional investors on an incentive basis.  Investment firms can make a profit by the difference between the unit cost to fill the order from the one quoted to the institutional investor."

Yeah! Big investment firms are banging at the door to get into a stock that on Thursday traded 870 shares on the TSX and on a typical day trades at LESS than the shares I own. They must be desperate. 

 "His current claim is management compensation explains the poor stock performance."

No!, my claim is they don't deserve the compensation they get considering the poor shareholders value. I would not object to the five excecutives getting $ 1 million between them, but certainly not $2 million + benefits. at this stage  of the game

".. who does he create for the development of Reolysin, Santa’s elves?  They work for free!"

No!, Dr.Lee  discovered  Reolysin and the people in the field are testing it, not the executives, and they are earning a hell of a lot less than BT, et,al.

Considering your myriad of Non de plumes and the above, I would have to quote Shakespeare, and I paraphase, ",,,An idiot by any other name is an idiot."
Bullboard Posts